Congratulations to all of the participants and sites that contributed to these treatments gaining approval!
FDA approves new flu shot using tiny needle for adults 18-64 years of age. Fluzone intradermal vaccine was studied across the PMG network. Read more.
FDA approves new type 2 diabetes treatment, Trajenta (linagliptin), which has been studied widely across the PMG network of sites. Learn more.
Clinical Trial Results:
Thank you to all of the participants and sites that contributed to these advancements in medicine!
Pneumonia vaccine studied across PMG network shown effective in adults over 50. Read more.
Clinical trial results for triglyceride drug studied PMG Research of Charleston, Hickory, Raleigh and Winston-Salem show significant reductions in triglyceride levels in patients that participated. Read more.
Positive results from Meniere's Disease drug studied at PMG Research of Salisbury, Winston-Salem and Wilmington- novel treatment is well-tolerated and demonstrates improvement in debiliating symptoms of severe inner ear disorder. Learn more.
Cholesterol medication studied at PMG Research of Raleigh demonstrates a lowering of LDL-C (bad cholesterol). Read more.